Research Report Covers Inflammatory Diseases Market Forecasts and Growth, 2017-2027
Future Market Insights has announced the addition of the “Inflammatory Diseases Market: Global Industry Analysis and Opportunity Assessment 2017-2027" report to their offering.
Future Market Insights has announced the addition of the “Inflammatory Diseases Market: Global Industry Analysis and Opportunity Assessment 2017-2027" report to their offering.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Inflammatory</strong> <strong>Diseases</strong> <strong>Market</strong><br />
February <strong>2017</strong><br />
<strong>Report</strong> Id : REP-GB-2723<br />
Status : Ongoing<br />
Category : Healthcare, Pharmaceuticals & Medical Devices<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved
About<br />
Future <strong>Market</strong> Insights<br />
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom<br />
research reports, <strong>and</strong> consulting services. We deliver a complete packaged solution, which<br />
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth<br />
insights, aerial view of the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC,<br />
ASEAN, <strong>and</strong> BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,<br />
Technology, Healthcare, <strong>and</strong> Retail.<br />
We have a global presence with delivery centers across India specializing in providing global<br />
research reports <strong>and</strong> country research reports. FMI is headquartered out of London, U.K., with a<br />
state-of-the-art delivery center located in Pune, India. We combine our knowledge <strong>and</strong> learning<br />
from every corner of the world to distill it to one thing – the perfect solution for our client.<br />
<strong>Research</strong> Capabilities<br />
Sector Coverage<br />
<br />
<br />
<br />
<br />
Customized <strong>Research</strong><br />
Syndicated <strong>Research</strong><br />
Investment <strong>Research</strong><br />
Social Media <strong>Research</strong><br />
<br />
<br />
<br />
<br />
Automotive <strong>and</strong> Transportation<br />
Electronics, Semiconductor, <strong>and</strong> ICT<br />
Retail <strong>and</strong> Consumer Products<br />
Industrial Automation <strong>and</strong> Equipment<br />
<br />
<br />
<br />
<br />
Chemicals & Materials<br />
Food <strong>and</strong> Beverages<br />
Services <strong>and</strong> Utilities<br />
Energy, Mining, Oil, <strong>and</strong> Gas<br />
Customized<br />
<strong>Research</strong><br />
Syndicated<br />
<strong>Research</strong><br />
Investment<br />
<strong>Research</strong><br />
Social Media<br />
<strong>Research</strong><br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
2
<strong>Research</strong> Methodology (1/2)<br />
Systematic <strong>Research</strong> Approach<br />
<strong>Market</strong> profiling<br />
Formulating discussion guide<br />
Developing list of respondents<br />
Data collection<br />
Data validation<br />
4<br />
5<br />
3<br />
1<br />
2<br />
In-depth secondary research is used to<br />
ascertain overall market size, top<br />
industry players, top products, industry<br />
associations, etc.<br />
PMR formulates a detailed discussion<br />
guide to conduct expert <strong>and</strong> industry<br />
interviews<br />
PMR develops a list of industry players<br />
(manufacturers), distributors, retailers<br />
<strong>and</strong> industry experts<br />
PMR conducts interviews with industry<br />
experts, industry players, distributors<br />
<strong>and</strong> retailers<br />
Data is validated by triangulation<br />
method, wherein secondary, primary<br />
<strong>and</strong> PMR analysis contribute to the final<br />
data<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Data<br />
Collection<br />
Data Filter<br />
& Analysis<br />
Identifying key opinion leaders<br />
Questionnaire design<br />
In-depth interviews<br />
Coverage across value chain<br />
<strong>Market</strong> participants<br />
Key strengths<br />
Product portfolio<br />
Mapping as per value chain<br />
Key focus segments<br />
A<br />
Primary<br />
<strong>Research</strong><br />
C<br />
Company<br />
Analysis<br />
<strong>Research</strong> &<br />
Intelligence<br />
SOLUTION<br />
Actionable<br />
Insights<br />
B<br />
Desk<br />
<strong>Research</strong><br />
<br />
<br />
<br />
<br />
<br />
<br />
Business<br />
Solution<br />
Key industry experts<br />
Channel study<br />
Developments<br />
<strong>Market</strong> dynamics<br />
Products<br />
Conclusions<br />
Data analysis<br />
6<br />
Data is scrutinized using MS-Excel to<br />
obtain qualitative <strong>and</strong> quantitative<br />
insights about the industry<br />
Primary <strong>Research</strong> #<br />
Secondary <strong>Research</strong> #<br />
Paid Publications#<br />
Insights<br />
7<br />
PMR delivers industry insights <strong>and</strong><br />
information in the required format<br />
(PDF)<br />
<br />
<br />
<br />
<br />
Linkedin<br />
Zoominfo<br />
Salesforce<br />
Avention<br />
<br />
<br />
<br />
<br />
Company websites<br />
Company annual<br />
reports<br />
White papers<br />
Financial reports<br />
<br />
<br />
<br />
<br />
Factiva<br />
GBI<br />
Genios<br />
Meltwater<br />
# includes sources of databases<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
3
<strong>Inflammatory</strong> <strong>Diseases</strong> <strong>Market</strong><br />
A new underst<strong>and</strong>ing of inflammatory diseases has changed the drug development l<strong>and</strong>scape for several<br />
major diseases that are affecting millions of people in the world. Inflammation describes the primary<br />
response of the body that eliminates the cause of injury. Periodically, body’s defense mechanism works<br />
inappropriately that leads to inflammation. Drug development has focused on treating each disease<br />
symptoms separately. The discovery of drugs to treat inflammatory diseases related with immune system<br />
is driving the market towards growth. Immune Mediated <strong>Inflammatory</strong> diseases represent a global threat<br />
in terms of quality of life, morbidity <strong>and</strong> mortality that leads to increasing opportunity to develop new<br />
treatments to conquer the inflammatory diseases <strong>and</strong> increase market share. On the top inflammatory<br />
diseases are most common in human beings. Increasing popularity of inflammatory diseases <strong>and</strong><br />
treatment followed by anti-inflammatory drugs with lesser side effects is driving the global inflammatory<br />
diseases market.<br />
Request <strong>Report</strong> Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-2723<br />
Based on type of diseases, global inflammatory diseases market can be segmented into following<br />
Respiratory <strong>Diseases</strong><br />
‣ Asthma<br />
‣ Chronic obstructive pulmonary disease<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 4
<strong>Inflammatory</strong> <strong>Diseases</strong> <strong>Market</strong><br />
Heart disease<br />
Multiple Sclerosis<br />
Psoriasis<br />
<strong>Inflammatory</strong> Bowel Disease<br />
Bone disease<br />
‣ Rheumatoid Arthritis<br />
‣ Osteoarthritis<br />
Others<br />
Based on type of drug class, global inflammatory diseases market can be segmented into following<br />
Anti-inflammatory Biologics<br />
Non-steroidal Anti-<strong>Inflammatory</strong> Drugs<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 5
<strong>Inflammatory</strong> <strong>Diseases</strong> <strong>Market</strong><br />
Corticosteroids<br />
Others<br />
Based on type of distribution channel, global inflammatory diseases market can be segmented into<br />
following<br />
Hospital pharmacy<br />
Retail pharmacy<br />
Drug stores<br />
Online pharmacy<br />
On the basis of type of disease global inflammatory diseases market is segmented into respiratory<br />
diseases, heart disease, multiple sclerosis, Psoriasis, inflammatory bowel disease, bone disease <strong>and</strong><br />
others. Respiratory diseases are further classified into asthma <strong>and</strong> chronic obstructive pulmonary<br />
disease, where asthma is a condition in that a person’s airways become swollen, narrow <strong>and</strong> inflamed to<br />
produce extra mucus <strong>and</strong> chronic obstructive pulmonary disease (COPD) is name for a group of lung<br />
conditions that causes due to smoking in adults that leads to breathing difficulties.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 6
<strong>Inflammatory</strong> <strong>Diseases</strong> <strong>Market</strong><br />
Heart disease or heart disorders are conditions in that heart stops functioning, there are several types of<br />
heart diseases like arrhythmias heart disease, atherosclerotic <strong>and</strong> cardiomyopathy. Multiple sclerosis is a<br />
degenerative disease that attack central nervous system <strong>and</strong> disrupts the flow of information within the<br />
brain. Psoriasis is systemic inflammation that causes red <strong>and</strong> flaky plaques with joint pain of psoriatic<br />
arthritis. <strong>Inflammatory</strong> bowel disease involves inflammation related with gastro intestinal tract, includes<br />
to most common diseases of gastro intestinal tract that are crohn’s disease <strong>and</strong> ulcerative disease. Bone<br />
disease mostly includes rheumatoid arthritis <strong>and</strong> osteoarthritis.<br />
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-2723<br />
Moreover, on the basis of drug class used in treatment of inflammatory diseases global inflammatory<br />
diseases market is segmented into non-steroidal anti-inflammatory drugs, anti-inflammatory biologics<br />
<strong>and</strong> corticosteroids. Non-steroidal anti-inflammatory drugs bound the production of hormones in the<br />
body such as prostagl<strong>and</strong>ins that is responsible for inflammation. Anti-inflammatory biologics are mostly<br />
used in treatment of arthritis indications in rheumatoid arthritis <strong>and</strong> osteoarthritis that is one of the<br />
revenue generating segment followed by respiratory diseases like asthma <strong>and</strong> chronic obstructive<br />
pulmonary disease. On the basis of distribution channel global inflammatory disease market is<br />
segmented into hospital pharmacy, retail pharmacy, drug stores <strong>and</strong> online pharmacy.<br />
Geographically, global inflammatory market is segmented into five key regions: North America, Latin<br />
America, Europe, Asia Pacific <strong>and</strong> Middle East Africa. North Amrica is dominating in inflammatory<br />
diseases market as there is dem<strong>and</strong> for br<strong>and</strong>ed medicines over the generic medicines.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 7
<strong>Inflammatory</strong> <strong>Diseases</strong> <strong>Market</strong><br />
Rising geriatric population is driving the inflammatory diseases market throughout the globe.<br />
Followed by North America, Asia Pacific <strong>and</strong> Latin America has shown increasing market share in<br />
inflammatory diseases.<br />
Some of the major players in global inflammatory diseases market are AstraZeneca, Merck & Co.,<br />
GlaxoSmithKline, Bristol-Myers Squibb, F-Hoffmann-La-Roche, Eli Lilly <strong>and</strong> Sanofi. Other emerging<br />
competitors like Enlivex Therapeutics Ltd., Gilead Sciences, Immune Pharmaceuticals, Merck,<br />
Mitsubishi Tanabe Pharma Corporation, Neovacs, Prometheus Laboratories, S<strong>and</strong>oz, <strong>and</strong> Takeda<br />
Pharmaceuticals are developing drug pipeline <strong>and</strong> launch of new products as key strategies.<br />
Full <strong>Report</strong> Analysis@ http://www.futuremarketinsights.com/reports/inflammatory-diseases-market<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 8
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
For media queries, contact the press office at<br />
press@futuremarketinsights.com<br />
For other queries contact:<br />
Hari. T (Sr. Manager - Global Business Development)<br />
Future <strong>Market</strong> Insights: 3rd Floor,<br />
207 Regent Street, London W1B 3HH<br />
T: +44 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
Thank You<br />
Future <strong>Market</strong> Insights Global & Consulting Private Limited (FMI)<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
9
Change language